| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |